Cargando…
Chikungunya virus: an update on antiviral development and challenges
Chikungunya virus (CHIKV) has re-emerged as a significant public health threat since the 2005 chikungunya fever epidemic in La Réunion. Driven by the medical importance of this virus, as well as the lack of approved antivirals, research into the field of CHIKV antivirals has recently intensified. Po...
Autores principales: | Kaur, Parveen, Chu, Justin Jang Hann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108317/ https://www.ncbi.nlm.nih.gov/pubmed/23684571 http://dx.doi.org/10.1016/j.drudis.2013.05.002 |
Ejemplares similares
-
The Interplay of Viral and Host Factors in Chikungunya Virus Infection: Targets for Antiviral Strategies
por: Wong, Kai Zhi, et al.
Publicado: (2018) -
Antiviral activity of silymarin against chikungunya virus
por: Lani, Rafidah, et al.
Publicado: (2015) -
Bortezomib inhibits chikungunya virus replication by interfering with viral protein synthesis
por: Kaur, Parveen, et al.
Publicado: (2020) -
Activity of andrographolide against chikungunya virus infection
por: Wintachai, Phitchayapak, et al.
Publicado: (2015) -
Antiviral Phosphorodiamidate Morpholino Oligomers are Protective against Chikungunya Virus Infection on Cell-based and Murine Models
por: Lam, Shirley, et al.
Publicado: (2015)